SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-184004
Filing Date
2023-07-10
Accepted
2023-07-07 21:39:00
Documents
12
Period of Report
2023-07-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d533683d8k.htm   iXBRL 8-K 23893
  Complete submission text file 0001193125-23-184004.txt   149280

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA surf-20230706.xsd EX-101.SCH 2862
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE surf-20230706_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE surf-20230706_pre.xml EX-101.PRE 11715
6 EXTRACTED XBRL INSTANCE DOCUMENT d533683d8k_htm.xml XML 3469
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38459 | Film No.: 231078086
SIC: 2836 Biological Products, (No Diagnostic Substances)